Healthcare Payors Agent Identity Vendor Selection | Moring
Selecting agent identity tooling for a healthcare payor should weight runtime enforcement over dashboard coverage. The differentiating questions are whether the vendor authenticates each agent at the point of each call, supports delegated per-user access, propagates revocation instantly, and integrates with the payor's directory and gateway estate. Demos show permissions neatly listed; production is where vendors separate runtime control planes from governance dashboards.
Short answer
Selecting agent identity tooling for a healthcare payor should weight runtime enforcement over dashboard coverage. The differentiating questions are whether the vendor authenticates each agent at the point of each call, supports delegated per-user access, propagates revocation instantly, and integrates with the payor's directory and gateway estate. Demos show permissions neatly listed; production is where vendors separate runtime control planes from governance dashboards.
How it works
Vendor evaluation for agent identity should start from a sober observation repeated across practitioner analysis: security solutions can appear complete in a demo yet fall short in production, and a dashboard that lists an agent's permissions is useful for an audit but does nothing at the moment the agent uses those permissions in an unexpected way. The scorecard that matters is how much of the agent runtime the vendor actually operates: whether it can authenticate the agent, evaluate the action, enforce the decision, and revoke access, all at the moment of the call rather than in a nightly reconciliation.
Runtime capability has a concrete technical meaning worth testing during evaluation. One vendor approach authenticates and authorizes agent-to-server connections at the point of the call rather than relying on a static key configured in advance, delivering short-lived credentials that carry the user context the agent is serving. Payors should ask each candidate how it handles that moment: does the platform verify the agent's registered identity per action, evaluate policy against the human it serves, and produce a per-call verdict that can be reconstructed later? Static API keys minted at onboarding answer none of these questions, whatever the console shows.
Coverage of the identity estate is the second axis. Agents authenticate through several paths: dedicated agent identities, machine credentials such as keys and tokens, and delegated human context, and an agent operating an authenticated browser may bypass tool gateways entirely. Discovery, certification, and broader identity governance may need to remain with the payor's existing identity governance tooling even when a runtime enforcement vendor handles the point-of-call decision, and vendors themselves acknowledge this division. The evaluation question is where each capability lives and whether the boundaries between products create blind spots at exactly the seams agents will exploit.
Healthcare-specific fit is the third axis. The vendor should support delegated per-user access patterns relevant to payor systems, propagate revocation immediately when directory accounts change, and log each action with enough context to reconstruct which agent acted for whom. Practitioner guidance is direct that a compelling demonstration is not evidence a system can operate safely in your environment, and that platform comparison is only useful after success criteria are clear across identity, tool control, policy enforcement, evaluation, observability, data handling, portability, cost, support, and rollback. For payors, evidence reconstruction and revocation speed deserve explicit weight in those criteria.
The diligence record should itself follow payor governance discipline: document the success criteria, the test results against each vendor's runtime behavior, and the boundary decisions about which capabilities remain in-house, so the selection is defensible later. This record also supports the EU AI Act context, since payors deploying agents in high-risk workflows need to show that their enforcement and evidence infrastructure, whatever its vendor composition, produces attributable, reconstructable records of automated decisions. A vendor chosen for dashboard elegance but weak runtime enforcement undermines that record at the moment it matters.
Frequently asked questions
What should a payor test first when evaluating agent identity vendors?
Test the runtime moment: whether the vendor authenticates the agent's registered identity at the point of each call, evaluates policy against the human the agent serves, and produces a per-call verdict that can be reconstructed later. Demos that list permissions in a dashboard are weak evidence, since such dashboards do nothing when an agent uses its permissions unexpectedly. Revocation speed and delegated per-user support deserve equal testing weight, because both determine whether control exists when it matters.
Can one vendor cover the whole payor agent identity estate?
Rarely. Runtime enforcement at the point of call, discovery and certification of the agent inventory, and lifecycle governance may sit in different products, and vendors themselves acknowledge the division. The evaluation should therefore map where each capability lives and probe the seams between products, since agents operating authenticated browsers or machine credentials can bypass tool gateways entirely. Payors should accept a composed estate deliberately, with documented boundaries, rather than discovering the gaps during an incident.
What healthcare-specific requirements should weigh in vendor selection?
Support for delegated per-user access so actions attribute to the acting staff member, immediate revocation propagation when directory accounts change, and per-action logging rich enough to reconstruct which agent acted for whom. Payors should define success criteria across identity, tool control, policy enforcement, observability, data handling, and rollback before comparing platforms, because a demonstration is not evidence the system operates safely in the payor's environment. Evidence reconstruction and revocation speed deserve explicit scoring weight given member-data sensitivity.
How should vendor selection be documented for compliance purposes?
Record the success criteria, the runtime test results for each candidate, and the boundary decisions about which capabilities remain in-house, retained like other governance artifacts. When the payor later demonstrates control over agents in high-risk workflows, including under the EU AI Act's documentation expectations, the selection record shows that enforcement and evidence infrastructure were chosen against stated requirements rather than adopted by default. It also disciplines future re-evaluations by making the original assumptions visible.